Indeed, in some cases it was possible to switch and follow-up, at a distance, patients with positive hormone receptors BC from neoadjuvant or adjuvant chemotherapy to hormonal therapy, or those with negative receptors BC to oral chemotherapy [25]. Here, NR4A1 is linked to breast cancer.